QURE
XNASUNIQURE NV
Avg. sentiment
0.30neutral
1 news · 90d
7d trend
——
0 news · vs previous 7d (0.30)
Breakdown
↑ 0• 1↓ 0
Sentiment velocity
+0.000→/day
Acceleration —
No price data available for this ticker.
Daily digest
Track $QURE sentiment without checking the page.
Top-discussed tickers and the AI sentiment we read. Not advice.
News · 1
How did the price react? →- UniQure to seek FDA approval for Huntington's disease gene therapy after previous clash with agency
UniQure announced it will seek FDA approval for its Huntington's disease gene therapy, following a prior public dispute with the agency over the clinical trial data supporting its application. The move comes months after the company and FDA leaders clashed over the adequacy of the trial data. No timeline for the formal submission was specified in the article.